비교리스트

 카트 문의
시장보고서
상품코드
1304163

생리통 치료제 시장 : 약물 유형별, 유형별, 투여 경로별, 제형별, 유통 채널별, 지역별 - 시장 규모, 점유율, 전망 및 기회 분석(2023-2030년)

Menstrual Cramps Treatment Market, By Drug Class, By Type, By Route of Administration, By Dosage Form, By Distribution Channel, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
발행일: | 리서치사: Coherent Market Insights | 페이지 정보: 영문 | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

생리통(월경통)은 하복부가 욱신거리거나 경련을 일으키는 통증을 말합니다. 많은 여성들이 월경 직전이나 월경 중 생리통이 발생합니다. 자궁내막증이나 자궁근종과 같은 질환이 생리통을 유발할 수도 있습니다. 하복부 통증, 복부 압박감, 엉덩이, 허리, 허벅지 안쪽의 통증 등의 증상이 나타납니다. 생리통 치료에는 이부프로펜(애드빌), 나프록센나트륨(아리브) 등 비스테로이드성 소염진통제(NSAIDs)와 같은 일반의약품이 사용됩니다. 또한, 마이펜블리(화이자)와 같은 호르몬 길항제도 생리통 치료에 사용됩니다.

시장 역학

시장 기업들은 생리통 치료를 위한 협업과 같은 무기 전략 증가에 초점을 맞추고 있으며, 이는 예측 기간 동안 세계 생리통 시장의 성장을 가속할 것으로 예상됩니다. 예를 들어, 2018년 4월 10일 세계 R&D 바이오제약 기업인 AbbVie와 Neurocrine Biosciences는 자궁내막증 관련 통증에 대한 Elagolix의 PDUFA(처방약 사용자 수수료법)를 발표했습니다. 엘라고릭스는 성선자극호르몬 방출 호르몬(GnRH) 수용체 길항제입니다. 경구 투여되며, 뇌하수체의 내인성 GnRH 수용체를 차단하는 단시간 작용형 분자입니다.

생리통의 유병률 증가는 예측 기간 동안 시장 성장을 가속할 것으로 예상됩니다. 예를 들어, 2022년 1월 14일 MDPI가 발표한 기사에 따르면 2019년 11월 7일부터 2020년 1월 30일까지 유럽 루마니아에서 전향적, 분석적, 관찰적 연구가 진행되었습니다. 이 연구에는 루마니아의 5개 대학 센터에서 1,720명이 참여했으며, 1,720명 중 1,349명(78.4%)이 월경곤란증을 앓고 있었습니다. 월경곤란증의 유병률은 16%에서 91%로 보고됐습니다. 가장 많이 사용된 약물은 비스테로이드성 항염증제로 741명(54.9%)이 사용했습니다.

또한 International Journal of Womens Health 저널에 실린 논문에 따르면, 에티오피아 남부에서 실시된 연구에서 전체 여학생의 원발성 월경통 유병률은 보고된 인구의 70%에 달했습니다.

본 조사의 주요 특징

  • 이 보고서는 세계 생리통 치료제 시장을 상세하게 분석헀으며, 2022년을 기준연도로 하여 예측 기간(2023-2030년) 시장 규모와 연평균 성장률(CAGR) 정보를 제공합니다.
  • 또한 다양한 부문의 잠재적 수익 기회를 파악하고, 이 시장에 대한 매력적인 투자 제안 매트릭스를 설명합니다.
  • 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채택한 경쟁 전략 등에 대한 주요 고찰도 제공합니다.
  • 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 성과 및 전략과 같은 매개 변수를 기반으로 세계 생리통 치료제 시장의 주요 기업을 프로파일링합니다.
  • 본 조사 대상의 주요 기업으로는 Pfizer Inc., Ingelheim International GmbH., Bayer AG, , Cipla Inc, Teva Pharmaceutical Industries Ltd., Sanofi, Johnson & Johnson Services, Inc., Dr. Reddy's Laboratories Ltd, Almatica Pharma LLC., F. Hoffmann-La Roche Ltd, GlaxoSmithKline Plc, Eisen Pharmaceutical Co.（Pvt.）Ltd., Emcure Pharmaceuticals, AbbVie., Sparsha Pharma International Pvt Ltd, Hope Medicine（Nanjing）Co., Ltd.가 있습니다.
  • 이 보고서의 통찰력을 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형화, 시장 확대 및 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
  • 세계 생리통 치료제 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
  • 이해관계자는 세계 생리통 치료제 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.

목차

제1장 조사 목적과 전제조건

  • 조사 목적
  • 전제조건
  • 약어

제2장 시장 상황 개요

  • 보고서 개요
    • 시장 정의와 범위
  • 주요 요약
  • Coherent Opportunity Map(COM)

제3장 시장 역학, 규제, 동향 분석

  • 시장 역학
    • 성장 촉진요인
    • 성장 억제요인
    • 시장의 매력 분석
    • 시장 기회
  • 제품 발표
  • 시장 동향
  • 인수합병(M&A) 및 협업
  • 규제 가이드라인과 컴플라이언스
  • 주요 발전
  • PEST 분석
  • 기술 상황
  • 가격 분석
  • 브랜드 분석
  • 투자와 자금조달
  • 시설 확장

제4장 세계의 생리통 치료제 시장 : 코로나바이러스(COVID-19) 유행의 영향

  • 정부 이니셔티브
  • COVID-19 역학
  • 주요 발전

제5장 세계의 생리통 치료제 시장 : 약제 클래스별, 2018년-2030년

  • 진통제
  • 항콜린제
  • 비스테로이드성 항염증제
  • 혈행 촉진제
  • 기타(특히 황체 호르몬제)

제6장 세계의 생리통 치료제 시장 : 유형별, 2018년-2030년

  • 원발성 생리통
  • 연발성 생리통

제7장 세계의 월경통 치료제 시장 : 투여 경로별, 2018년-2030년

  • 경구제
  • 주사제
  • 국소
  • 기타(자궁내, 기타)

제8장 세계의 생리통 치료제 시장 : 제형별, 2018년-2030년

  • 정제
  • 캡슐
  • 현탁액
  • 기타(경피 패치, 기타)

제9장 세계의 생리통 치료제 시장 : 유통 채널별, 2018년-2030년

  • 병원 약국
  • 소매 약국
  • 온라인 약국

제10장 세계의 생리통 치료제 시장 : 지역별, 2018년-2030년

  • 북미
  • 미국
  • 캐나다
  • 라틴아메리카
  • 브라질
  • 멕시코
  • 아르헨티나
  • 기타 라틴아메리카
  • 유럽
  • 영국
  • 독일
  • 이탈리아
  • 프랑스
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 중국
  • 인도
  • 일본
  • ASEAN
  • 호주
  • 한국
  • 기타 아시아태평양
  • 중동
  • GCC
  • 이스라엘
  • 기타 중동
  • 아프리카
  • 북아프리카
  • 중앙아프리카
  • 남아프리카

제11장 경쟁 구도

  • Pfizer, Inc.
  • Ingelheim International GmbH
  • Bayer AG
  • Abbott
  • Cipla Inc
  • Teva Pharmaceutical Industries Ltd.
  • Sanofi
  • Johnson & Johnson Services, Inc.
  • Reddy's Laboratories Ltd
  • Almatica Pharma LLC.
  • F. Hoffmann-La Roche Ltd
  • GlaxoSmithKline Plc
  • Eisen Pharmaceutical Co.(Pvt.) Ltd
  • Emcure Pharmaceuticals
  • AbbVie
  • Sparsha Pharma International Pvt Ltd.
  • Hope Medicine(Nanjing) Co., Ltd

제12장 섹션

  • 조사 방법
  • 출판사에 대해
LSH 23.08.09

Menstrual cramps (dysmenorrhea) are throbbing or cramping pains in the lower abdomen. Many women have menstrual cramps just before and during their menstrual periods. Conditions such as endometriosis or uterine fibroids can cause menstrual cramps. Symptoms occurred like aching pain in lower abdomen, a feeling of pressure in belly, pain in hips, lower back, and inner thighs. To treat menstrual cramps, over-the-counter pain relievers such as NSAID's like ibuprofen (Advil), Naproxen sodium (Aleve) are used. Hormonal antagonists drugs such as MYFEMBREE (Pfizer) also used for the treatment of menstrual cramps.

Market Dynamics

Market players in the market are focusing on ncreasing inorganic strategies such as collaboration for menstrual cramp treatment is expected to drive the the global menstrual cramp market growth over the forecast period. For instance, on April 10, 2018, AbbVie, a global research and development-based biopharmaceutical company, and Neurocrine Biosciences, announced PDUFA (Prescription Drug User Fee Act) for Elagolix in endometriosis-associated pain.. Elagolix is a gonadotropin-releasing hormone (GnRH) receptor antagonist. It is administered orally, and is a short-acting molecule that blocks endogenous GnRH receptors in the pituitary gland.

Increasing prevalence of menstrual cramps is expected to drive the market growth over the forecast period. For instance, on January 14, 2022, article published by MDPI, stated that a study was conducted in Europe's Romania in prospective, analytical, observational and took place between 7 November 2019 and 30 January 2020. This study included a population of 1720 from five university centers throughout the country. Out of 1,720 participants, 1,349 (78.4%) had dysmenorrhea. The prevalence of dysmenorrhea, ranging from 16% to 91% has been reported. The most widely used drugs were non-steroidal anti-inflammatory drugs, utilized by 741 students (54.9%) has been reported.

Moreover, according to article published by International Journal of Womens Health, a study was conducted in Southern Ethiopia, the prevalence of primary dysmenorrhea among all the female students is 70% of population who reported.

Key features of the study:

  • This report provides in-depth analysis of the global menstrual cramps treatment market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global menstrual cramps treatment market based on the following parameters company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Pfizer Inc., Ingelheim International GmbH., Bayer AG, , Cipla Inc, Teva Pharmaceutical Industries Ltd., Sanofi, Johnson & Johnson Services, Inc., Dr. Reddy's Laboratories Ltd, Almatica Pharma LLC., F. Hoffmann-La Roche Ltd, GlaxoSmithKline Plc, Eisen Pharmaceutical Co. (Pvt.) Ltd., Emcure Pharmaceuticals, AbbVie., Sparsha Pharma International Pvt Ltd, Hope Medicine (Nanjing) Co., Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global menstrual cramps treatments market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global menstrual cramps treatments market

Detailed Segmentation:

  • Global Menstrual Cramp Treatment Market, By Drug Class:
    • Analgesics
    • Anticholinergic
    • Non-steroidal anti-inflammatory drugs (NSAIDs)
    • Haematinics
    • Others (Progestins, Among others)
  • Global Menstrual Cramp Treatment Market, By Type:
    • Primary Dysmenorrhea
    • Secondary Dysmenorrhea
  • Global Menstrual Cramp Treatment Market, By Route of Administration:
    • Oral
    • Injectable
    • Topical
    • Others (Intrauterine, Others)
  • Global Menstrual Cramp Treatment Market, By Dosage Form:
    • Tablet
    • Capsules
    • Suspension
    • Others (Transdermal Patch, Among others)
  • Global Menstrual Cramp Treatment Market, By Distribution channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Menstrual Cramps Treatment Market, By Region:
    • North America
      • By Country:
    • U.S.
    • Canada
    • Latin America
      • By Country:
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Europe
      • By Country:
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
      • By Country
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
      • By Country:
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
      • By Country/Region:
    • South Africa
    • Central Africa
    • North Africa
  • Company Profiles
    • Pfizer Inc.*
      • Company Highlights
      • Products Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Ingelheim International GmbH PerkinElmer Inc.
    • Bayer AG
    • Abbott.
    • Cipla Inc
    • Teva Pharmaceutical Industries Ltd.
    • Sanofi
    • Johnson & Johnson Services, Inc.
    • Dr. Reddy's Laboratories Ltd
    • Almatica Pharma LLC.
    • F. Hoffmann-La Roche Ltd
    • GlaxoSmithKline Plc
    • Eisen Pharmaceutical Co. (Pvt.) Ltd.
    • Emcure Pharmaceuticals
    • AbbVie.
    • Sparsha Pharma International Pvt Ltd.
    • Hope Medicine (Nanjing) Co., Ltd

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Drug Class
    • Market Snapshot, By Type
    • Market Snapshot, By Route of administration
    • Market Snapshot, By Dosage Form
    • Market Snapshot, By Distribution channel
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Attractiveness Analysis
    • Market Opportunities
  • Product Launches
  • Market Trends
  • Merger, Acquisition, Collaborations
  • Regulatory Guideline and Compliances
  • Key Developments
  • PEST Analysis
  • Technology Landscape
  • Pricing Analysis
  • Brand Analysis
  • Investments and Funding
  • Facility Expansions

4. Global Menstrual Cramps Treatment Market- Impact of Coronavirus (Covid-19) Pandemic

  • Government Initiatives
  • COVID-19 Epidemiology
  • Key Developments

5. Global Menstrual Cramps Treatment Market, By Drug Class, 2018-2030, (US$ Million)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Analgesics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Anticholinergics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Non-steriodal anti-inflammatory drugs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Haematinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Others (Progestins, Among others)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)

6. Global Menstrual Cramps Treatment Market, By Type, 2018 - 2030, (US$ Million)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Primary Dysmenorrhea
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Secondary Dysmenorrhea
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)

7. Global Menstrual Cramps Treatment Market, By Route of administration, 2018 - 2030, (US$ Million)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segments Trends
  • Oral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Injectable
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Topical
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Others (Intrauterine, Among others)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)

8. Global Menstrual Cramps Treatment Market, By Dosage Form, 2018 - 2030, (US$ Million)

  • Tablet
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Capsules
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Suspension
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Others (Transdermal Patch, Among others)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)

9. Global Menstrual Cramps Treatment Market, By Distribution channel, 2018 - 2030, (US$ Million)

  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)

10. Global Menstrual Cramps Treatment Market, By Region, 2018 - 2030, (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Region, 2018-2030
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of administration, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution channel, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Million)
  • U.S.
  • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of administration, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution channel, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Million)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of administration, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution channel, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Million)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of administration, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution channel, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Million)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of administration, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution channel, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Million)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of administration, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution channel, 2018 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Million)
  • North Africa
  • Central Africa
  • South Africa

11. Competitive Landscape

  • Pfizer, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Ingelheim International GmbH
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Bayer AG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Abbott
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Cipla Inc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Teva Pharmaceutical Industries Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Sanofi
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Johnson & Johnson Services, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Reddy's Laboratories Ltd
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Almatica Pharma LLC.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • F. Hoffmann-La Roche Ltd
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • GlaxoSmithKline Plc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Eisen Pharmaceutical Co. (Pvt.) Ltd
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Emcure Pharmaceuticals
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • AbbVie
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Sparsha Pharma International Pvt Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Hope Medicine (Nanjing) Co., Ltd
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies

12. Section

  • Research Methodology
  • About Us
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제